Loading ...

PsA Treatment With hOKT3γ1 (Ala-Ala)

(

PART

)

ITN Protocol #:

ITN011AI

Branded Name:

PART

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Treatment of Psoriatic Arthritis With hOKT3γ1 (Ala-Ala)

Clinical Operations Manager

ITN Biologist

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Marcus Clark, MD mclark@medicine.bsd.uchicago.edu

Work:

(773) 702-6119

Protocol Chair

Patti Tosta ptosta@immunetolerance.org

Work:

415-353-4421

Protocol Chair

Kristina Harris, PhD kharris@immunetolerance.org

Work:

240-235-6154

Protocol Chair

Peggy Fitzgibbon peggy.fitzgibbon@nih.gov

Work:

240-627-3505

Protocol Chair

David Weitzenkamp david_weitzenkamp@rhoworld.com

Work:

919-595-6422

Protocol Chair

Deborah Simpson Deborah.Simpson@ppdi.com

Work:

910 207 0463

Admin Links

Shortcuts

ITN Documents

Links